Home / Healthcare/ Ceyoka launches KeenMind for natural cognitive support

Ceyoka launches KeenMind for natural cognitive support


Comments / {{hitsCtrl.values.hits}} Views / Friday, 23 December 2016 00:00


In today’s fast paced world, clarity of memory and improved concentration are crucial cognitive abilities. Several randomised placebo clinical trials have demonstrated that the ayurvedic herb extract ‘Bacopamonnieri’, promotes mental clarity in both children and adults. Sri Lankans refer to this plant as ‘luniwila’.

Recognising its importance, Ceyoka, among the country’s premier conglomerates now offers KeenMind, (Bacopamonnieri extract CDRI 08), a natural nutraceutical for optimal cognitive support. KeenMind’s ability to help improve mental performance makes it suitable for mature adults who are seeking to prevent age-related memory decline and who are also looking to maintain healthy memory and cognitive function. 

KeenMind can also assist students by supporting memory, concentration and learning retention. Its anxiolytic and stress adaptation properties give the added advantage of calm focus. This can be particularly beneficial during times when mental clarity and performance are compromised by stress or mild anxiety, for example during exam times.  

“We believe this is a unique product in its classification for cognitive health benefits and KeenMind scores high in aiding memory and concentration, age-related cognitive decline and learning retention. Through Ceyoka, consumers have access to an efficacious and safe herbal medicinal product designed to help meet their specific needs,” said Ceyoka Health Ltd. CEO Dr. Syed Qamar Ali.

KeenMind is manufactured in Switzerland by SohoFlordis International (SFI), a global natural medicine company and Ceyoka’s pharmaceutical division is the authorised sole agent in Sri Lanka.

SohoFlordis International (SFI) is committed to identify and develop leading natural medicines with the best evidence of effectiveness, quality and safety, and marketing them around the world.

“We are pleased to have established a strong relationship with Ceyoka. KeenMind is a prime example of SFI’s dedication to developing new products to satisfy the unmet needs of patients and the doctors who treat them, as well as validating the marketplace’s demand for new and innovative products,” noted SFI South Asia Project Manager Dr. Dilip Ghosh.

The ideal dosage for children above seven years is one tablet daily with breakfast whilst for adults two tablets with breakfast is recommended. 

KeenMind which has been recently launched in Sri Lanka is available as an over-the-counter drug which can also be prescribed by doctors and homoeopaths. 

Ceyoka’s Pharma division is recognised as a leading pharmaceutical distribution entity in Sri Lanka with a product portfolio of high-end drugs from USA, Switzerland, China, India, Pakistan, Malaysia, Korea etc. The team encompasses individuals who are professional and proactive. Ceyoka Pharma’s strengths lie in its business partners, loyal customer base and an island-wide network.


Share This Article


COMMENTS

Today's Columnists

Bringing beedi into tax net can yield Rs. 40 b in revenue

Tuesday, 24 October 2017

Last week, the Financial Times quoted an AFP article that stated Sri Lanka will start regulating the toddy industry to boost tax revenues from the informal sector. This same principle should be applied to the beedi trade, which has also grown unabate


Grade 5 Scholarship examination and the future of the country

Tuesday, 24 October 2017

The Grade 5 scholarship examination results have been released recently. Although this is known as the “Mothers’ exam,” the mentality of the children can be well articulated when children come from the examination halls after the exams. Today w


Need for tax reforms: Government should not lose it this time but go for them early

Monday, 23 October 2017

In the first economic policy statement, Prime Minister Ranil Wickremesinghe made a number of pledges related to taxes and tax reforms. One was that the Government would review whether the tax concessions given to investors have really delivered the e


Lessons from Geneva

Saturday, 21 October 2017

‘Mission Impossible – Geneva’ is an inspiring account of developments at the Human Rights Council in Geneva when Dayan Jayatilleka was our Permanent Representative there. It is written by his wife Sanja, which provides for fascinating insights


Columnists More